BR9105237A - PROTEINS, PEPTIDES, DNA SEQUENCES, DNA OR RNA HYBRIDIZATION EVIDENCE, ANTIBODY, TUBERCULOSIS IMMUNE DIAGNOSIS, MICROORGANISM, TUBERCULOSIS VACCINE, PROCESS FOR TUBERCULOSIS TUBERCULOSIS TUBERCULOSIS - Google Patents

PROTEINS, PEPTIDES, DNA SEQUENCES, DNA OR RNA HYBRIDIZATION EVIDENCE, ANTIBODY, TUBERCULOSIS IMMUNE DIAGNOSIS, MICROORGANISM, TUBERCULOSIS VACCINE, PROCESS FOR TUBERCULOSIS TUBERCULOSIS TUBERCULOSIS

Info

Publication number
BR9105237A
BR9105237A BR919105237A BR9105237A BR9105237A BR 9105237 A BR9105237 A BR 9105237A BR 919105237 A BR919105237 A BR 919105237A BR 9105237 A BR9105237 A BR 9105237A BR 9105237 A BR9105237 A BR 9105237A
Authority
BR
Brazil
Prior art keywords
tuberculosis
dna
microorganism
peptides
antibody
Prior art date
Application number
BR919105237A
Other languages
Portuguese (pt)
Inventor
Jagannath Chinnaswamy
Balganesh Meenakshi
Ramasastry Srinivasa Bachally
Original Assignee
Astra Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Ab filed Critical Astra Ab
Publication of BR9105237A publication Critical patent/BR9105237A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/12Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1267Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-positive bacteria
    • C07K16/1289Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-positive bacteria from Mycobacteriaceae (F)
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/35Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Mycobacteriaceae (F)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2317/00Immunoglobulins specific features
    • C07K2317/30Immunoglobulins specific features characterized by aspects of specificity or valency
    • C07K2317/34Identification of a linear epitope shorter than 20 amino acid residues or of a conformational epitope defined by amino acid residues

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
BR919105237A 1990-03-27 1991-03-22 PROTEINS, PEPTIDES, DNA SEQUENCES, DNA OR RNA HYBRIDIZATION EVIDENCE, ANTIBODY, TUBERCULOSIS IMMUNE DIAGNOSIS, MICROORGANISM, TUBERCULOSIS VACCINE, PROCESS FOR TUBERCULOSIS TUBERCULOSIS TUBERCULOSIS BR9105237A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9001105A SE9001105D0 (en) 1990-03-27 1990-03-27 NEW METHODS FOR DIAGNOSIS OR TUBERCULOSIS
PCT/SE1991/000225 WO1991014448A1 (en) 1990-03-27 1991-03-22 New proteins, peptides and corresponding dna or rna sequences and probes useful for diagnosing tuberculosis

Publications (1)

Publication Number Publication Date
BR9105237A true BR9105237A (en) 1992-07-21

Family

ID=20379003

Family Applications (1)

Application Number Title Priority Date Filing Date
BR919105237A BR9105237A (en) 1990-03-27 1991-03-22 PROTEINS, PEPTIDES, DNA SEQUENCES, DNA OR RNA HYBRIDIZATION EVIDENCE, ANTIBODY, TUBERCULOSIS IMMUNE DIAGNOSIS, MICROORGANISM, TUBERCULOSIS VACCINE, PROCESS FOR TUBERCULOSIS TUBERCULOSIS TUBERCULOSIS

Country Status (10)

Country Link
EP (1) EP0479971A1 (en)
CN (1) CN1060310A (en)
AU (1) AU7564491A (en)
BR (1) BR9105237A (en)
IL (1) IL97572A0 (en)
JO (1) JO1671B1 (en)
PT (1) PT97150A (en)
SE (1) SE9001105D0 (en)
WO (1) WO1991014448A1 (en)
ZA (1) ZA911855B (en)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2313719T3 (en) 1993-11-23 2009-03-01 The Regents Of The University Of California ABUNDANT EXTRACELLULAR PRODUCTS AND PROCEDURE OF PRODUCTION AND USE OF THE SAME.
US6752993B1 (en) 1993-11-23 2004-06-22 The Regents Of The University Of California Abundant extracellular product vaccines and methods for their production and use
US7300660B2 (en) 1993-11-23 2007-11-27 The Regents Of The University Of California Abundant extracellular products and methods for their production and use
US6290969B1 (en) 1995-09-01 2001-09-18 Corixa Corporation Compounds and methods for immunotherapy and diagnosis of tuberculosis
US6338852B1 (en) 1995-09-01 2002-01-15 Corixa Corporation Compounds and methods for diagnosis of tuberculosis
US6458366B1 (en) 1995-09-01 2002-10-01 Corixa Corporation Compounds and methods for diagnosis of tuberculosis
US6592877B1 (en) 1995-09-01 2003-07-15 Corixa Corporation Compounds and methods for immunotherapy and diagnosis of tuberculosis
US6013660A (en) * 1996-10-02 2000-01-11 The Regents Of The University Of California Externally targeted prophylactic and chemotherapeutic method and agents
US6465633B1 (en) 1998-12-24 2002-10-15 Corixa Corporation Compositions and methods of their use in the treatment, prevention and diagnosis of tuberculosis
CN103063836B (en) * 2011-10-18 2016-03-30 复旦大学附属华山医院 Detect the reagent of mycobacterial infections, method and kit
CN111518165B (en) * 2020-05-08 2021-10-01 宁夏大学 Polypeptide specifically binding to mycobacterium tuberculosis, coding gene and application thereof
CN112125954B (en) * 2020-09-28 2023-02-28 宁夏医科大学总医院 Heptapeptide specifically combined with BCG (bacillus calmette guerin), coding gene, preparation method and application

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1988005823A2 (en) * 1987-02-02 1988-08-11 Whitehead Institute For Biomedical Research Mycobacterium tuberculosis genes encoding protein antigens
US4952395A (en) * 1987-02-26 1990-08-28 Scripps Clinic And Research Foundation Mycobacterial recombinants and peptides

Also Published As

Publication number Publication date
ZA911855B (en) 1991-12-24
AU7564491A (en) 1991-10-21
EP0479971A1 (en) 1992-04-15
WO1991014448A1 (en) 1991-10-03
SE9001105D0 (en) 1990-03-27
IL97572A0 (en) 1992-06-21
JO1671B1 (en) 1992-08-09
PT97150A (en) 1991-12-31
CN1060310A (en) 1992-04-15

Similar Documents

Publication Publication Date Title
BR9105237A (en) PROTEINS, PEPTIDES, DNA SEQUENCES, DNA OR RNA HYBRIDIZATION EVIDENCE, ANTIBODY, TUBERCULOSIS IMMUNE DIAGNOSIS, MICROORGANISM, TUBERCULOSIS VACCINE, PROCESS FOR TUBERCULOSIS TUBERCULOSIS TUBERCULOSIS
WO1995018826A3 (en) Purified primate ctla-8 antigens and related reagents
NZ540544A (en) Nucleic acids and proteins from streptococcus groups A & B
BR9710968A (en) Human B cell antigens; related reagents
ATE26127T1 (en) RECOMBINANT DNA, HOST ORGANISMS TRANSFORMED WITH IT AND POLYPEPTIDES PRODUCED BY THE HOST ORGANISMS; PROCESSES FOR THEIR MANUFACTURE; DETECTION METHODS USING THE POLYPEPTIDES; COMPOSITIONS AND AGENTS CONTAINING THE POLYPEPTIDES; DNA SEQUENCES.
DK0942983T3 (en) Streptococcus pneumoniae antigens and vaccines
DE262192T1 (en) METHOD AND MEANS FOR PRODUCING A PROTEIN WITH THE SAME IGG SPECIFICITY AS PROTEIN G.
WO1998008542A3 (en) Compounds and methods for treatment and diagnosis of mycobacterial infections
NZ296748A (en) Peripheral nervous system specific sodium channel proteins, DNA coding therefor, compositions and methods
MX9101042A (en) RECOMBINANT DNA AND RNA AND PRODUCTS DERIVED FROM THEM
DE3484377D1 (en) PEPTIDES, PHARMACEUTICAL COMPOSITIONS, GENES, VECTORS, HOST ORGANISMS, METHOD FOR THEIR PRODUCTION AND DIAGNOSTIC REAGENTS.
WO2000042188A3 (en) Interleukin-17 related mammalian cytokines. polynucleotides encoding them. uses
ATE350055T1 (en) HAEMOPHILUS INFLUENZAE ADHERENCE AND PENATRATION PROTEINS
WO2000006736A3 (en) Nucleic acids and proteins from group b streptococcus
WO1996021734A3 (en) P15 and tyrosinase melanoma antigens and their use in diagnostic and therapeutic methods
EP0834568A3 (en) Novel saliva binding protein
WO1998023750A3 (en) Mammalian chemokines
ATE417106T1 (en) CHLAMYDIA ANTIGENS AND THEIR CORRESPONDING DNA FRAGMENTS AND USES THEREOF
ES2171709T3 (en) NEW SEQUENCING PROCEDURE FOR OLIGOMEROS HYBRIDIZATION.
ATE335821T1 (en) METHODS AND COMPOSITIONS FOR DIAGNOSING ROCHALIMAEA HENSELAE AND ROCHALIMAEA QUINTANA INFECTION
ATE294237T1 (en) MAMMAL THYMOKEGENS
BR9607406A (en) Isolated dna molecule isolated protein or polypeptide process to vaccinate mammals against mycobacterium tuberculosis infection recombinant dna expression system vaccine host to prevent infection and mammalian disease by mycobacterium tuberculosis process to vaccinate mammals isolated antibody or binding moiety same process and composition to passively imminate mammals infected with mycobacterium tuberculosis processes to detect mycobacterium tuber
ES2092568T3 (en) IDENTIFICATION OF NEW DRUGS AND REAGENTS.
WO2005022160A3 (en) Diagnosis and treatment of micobacterial infections
WO2000006743A3 (en) Chlamydia antigens and corresponding dna fragments and uses thereof

Legal Events

Date Code Title Description
B15K Others concerning applications: alteration of classification

Ipc: C07K 16/12 (2006.01), C07K 14/35 (2006.0